Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05949788Completed

Analyses of Anemia in Very Low Birth Weight (VLBW) Infants.

Role: lead

NCT06369584Not ApplicableRecruiting

Prone Position During ECMO in Pediatric Patients With Severe ARDS

Role: collaborator

NCT05481866Not ApplicableUnknown

Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum

Role: collaborator

NCT03251898Completed

Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections

Role: collaborator

NCT02552706Not ApplicableUnknown

The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis

Role: lead

All 5 trials loaded